A variant of position -308 of the Tumour necrosis factor alpha gene promoter and the risk of coronary heart disease

Heart Lung and Circulation

Volumn 17, Issue 1, 2008, Pages 14-18

  Elahi, Maqsood M ^a   Gilmour, Ashley ^a   Matata, Bashir M ^b   Mastana, Sarabjit S ^a  

^a LOUGHBOROUGH UNIVERSITY   (United Kingdom)

^b LIVERPOOL HEART AND CHEST HOSPITAL   (United Kingdom)

Author keywords

Cardiovascular disease; Genetic susceptibility; Single nucleotide polymorphism; TNF alpha

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GENOMIC DNA; NITRATE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CAUCASIAN; CONTROLLED STUDY; CORONARY RISK; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HIGH RISK POPULATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED KINGDOM;

AGE DISTRIBUTION; AGED; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; CORONARY ANGIOGRAPHY; CORONARY DISEASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GREAT BRITAIN; HUMANS; INCIDENCE; MALE; MIDDLE AGED; ODDS RATIO; PILOT PROJECTS; POLYMORPHISM, GENETIC; PROBABILITY; PROGNOSIS; PROMOTER REGIONS (GENETICS); REFERENCE VALUES; RISK ASSESSMENT; SEX DISTRIBUTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 37049030665     PISSN: 14439506     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hlc.2007.05.009     Document Type: Article

References (29)

1. Vassali P. The pathophysiology of tumor necrosis factors. Annu Rev Immunol 10 (1992) 411
2. Hajeer A.H., and Hutchinson I.V. TNF-a gene polymorphism: clinical and biological implications. Micros Res Tech 50 (2000) 216-228
3. Cuenca J., Perez C.A., Aguirre A.J., Schiattino I., and Aguillon J.C. Genetic polymorphism at position-308 in the promoter region of the tumor necrosis factor (TNF): implications of its allelic distribution on susceptibility or resistance to diseases in the Chilean population. Biol Res 34 (2001) 237-241
4. Abraham L.J., and Kroeger K.M. Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease. J Leukoc Biol 66 (1999) 562-566
5. Westendorp R.G.J., Langermans J.A.M., Huizinga T.W.J., Elouali A.H., Verweij C.L., Boomsma D.I., and Vandenbroucke J.P. Genetic influence on cytokine production and fatal meningococcal disease. Lancet 349 (1997) 170-173
6. Wilson A.G., di Giovine F.S., Blakemore A.I., and Duff G.W. Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1 (1992) 353
7. Wilson A.G., Symons J.A., McDowell T.L., McDevitt H.O., and Duff G.W. Effects of a polymorphism in the human tumor necrosis factor-α promoter on transcriptional activation. Proc Natl Acad Sci USA 94 (1997) 3195-3199
8. Braun N., Michel U., Ernst B.P., Metzner R., Bitsch A., Weber F., and Rieckmann P. Gene polymorphism at position -308 of the tumor necrosis factor-α (TNF-α) in multiple sclerosis and its influence on the regulation of TNFα production. Neurosci Lett 215 (1996) 74-78
9. Allen R.A., Lee E.M., Roberts D.H., Park B.K., and Pirmohamed M. Polymorphisms in the TNF-alpha and TNF-receptor genes in patients with coronary artery disease. Eur J Clin Invest 31 10 (2001) 843-851
10. Koch W., Kastrati A., Bottiger C., Mehilli J., von Beckerath N., and Schomig A. Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction. Atherosclorosis 159 1 (2001) 137-144
11. Gupta V., Sarin B.C., Changotra H., and Sehajpal P.K. Association of G-308A TNF-alpha polymorphism with bronchial asthma in a North Indian population. J Asthma 42 (2005) 839-841
12. Witte J.S., Palmer L.J., O'Connor R.D., Hopkins P.J., and Hall J.M. Relation between tumour necrosis factor polymorphism TNFalpha-308 and risk of asthma. Eur J Hum Genet 10 (2002) 82-85
13. Zhang D.L., Li J.S., Jiang Z.W., Yu B.J., Tang X.M., and Zheng H.M. Association of two polymorphisms of tumor necrosis factor gene with acute biliary pancreatitis. World J Gastroenterol 9 (2003) 824-828
14. Densem C.G., Hutchinson I.V., Yonan N., and Brooks N.H. Tumour necrosis factor alpha gene polymorphism: a predisposing factor to non-ischaemic myocardial dysfunction?. Heart 87 (2002) 153-155
15. Kubota T., McNamara D.M., Wang J.J., Trost M., McTiernan C.F., Mann D.L., and Feldman A.M. Effects of tumor necrosis factor gene polymorphisms on patients with congestive heart failure. VEST Investigators for TNF Genotype Analysis. Vesnarinone Survival Trial. Circulation 97 (1998) 2499-2501
16. Mira J.P., Cariou A., Grall F., Delclaux C., Losser M.R., Heshmati F., Cheval C., Monchi M., Teboul J.L., Riche F., Leleu G., Arbibe L., Mignon A., Delpech M., and Dhainaut J.F. Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA 282 (1999) 561-568
17. Stuber F., Petersen M., Bokelmann F., and Schade U. A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis. Crit Care Med 24 (1996) 381-384
18. Bouma G., Crusius J.B., Oudkerk Pool M., Kolkman J.J., von Blomberg B.M., Kostense P.J., Giphart M.J., Schreuder G.M., Meuwissen S.G., and Pena A.S. Secretion of tumour necrosis factor and lymphotoxin in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. Scand J Immunol 43 (1996) 456-463
19. Danis V.A., Millington M., Hyland V., Lawford R., Huang Q., and Grennan D. Increased frequency of the uncommon allele of a tumour necrosis factor alpha polymorphism in rheumatoid arthritis and systemic lupus erythromatosis. Dis Markers 12 (1995) 127-133
20. Rood M.J., van Krugten M.V., Zanelli E., van der Linden M.W., Keijsers V., Schreuder G.M., Verduyn W., Westendorp R.G., de Vries R.R., Breedveld F.C., Verweij C.L., and Huizinga T.W. TNF -308 and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythromatosis. Arthritis Rheum 43 (2000) 129-134
21. Collins J.S., Perry R.T., Watson Jr. B., Harrell L.E., Acton R.T., Blacker D., Albert M.S., Tanzi R.E., Bassett S.S., McInnis M.G., Campbell R.D., and Go R.C. Association of a haplotype for tumor necrosis factor in siblings with late-onset Alzheimer disease: the NIMH Alzheimer Disease Genetics Initiative. Am J Med Genet 96 (2000) 823-830
22. Rudwaleit M., Siegert S., Yin Z., Eick J., Thiel A., Radbruch A., Sieper J., and Braun J. Low T cell production of TNF alpha and IFN gamma in ankylosing spondylitis: its relation to HLA-B27 and influence of the TNF-308 gene polymorphism. Ann Rheum Dis 60 (2001) 36-42
23. Schroeder S., Borger N., Wrigge H., Welz A., Putensen C., Hoeft A., and Stuber F. A tumor necrosis factor gene polymorphism influences the inflammatory response after cardiac operation. Ann Thorac Surg 75 (2003) 534-537
24. Tamasdottir H., Hjartarson H., Ricksten A., Wasslavik C., Bengtsson A., and Ricksten S.E. Tumor necrosis factor gene polymorphism is associated with enhanced systemic inflammatory response and increased cardiopulmonary morbidity after cardiac surgery. Anesth Analg 97 (2003) 944-949
25. Bittar M.N., Carey J.A., Barnard J.B., Pravica V., Deiraniya A.K., Yonan N., and Hutchinson I.V. Tumor necrosis factor alpha influences the inflammatory response after coronary surgery. Ann Thorac Surg 81 (2006) 132-137
26. Dedoussis G.V., Panagiotakos D.B., Vidra N.V., Louizou E., Chrysohoou C., Germanos A., Mantas Y., Tokmakidis S., Pitsavos C., and Stefanadis C. Association between TNF-alpha -308G>A polymorphism and the development of acute coronary syndromes in Greek subjects: the CARDIO2000-GENE Study. Genet Med 7 (2005) 411-416
27. Stemme S., Faber B., Holm J., Wilkund O., Witzum J.L., and Hansson G.K. T lymphocytes from human atherosclerotic plaques recognise oxidised low density lipoprotein. Proc Natl Acad Sci U S A 92 (1995) 3893-3897
28. Patel P., Mendall M.A., Carrington D., Strachan D.P., Leatham E., Molineaux N., Levy J., Blakeston C., Seymour C.A., Camm A.J., and Northfield T.C. Association of Helicobacter pylori and chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ 311 (1995) 711-714
29. Topol E.J., and Van de Werf F.J. Acute myocardial infarction. Early diagnosis and management. In: Topol E.J. (Ed). Textbook of cardiovascular medicine (1998), Lippincott-Raven, Philadelphia 395-435